Certara
Certara provides biosimulation software and technology-driven services to help you accelerate drug development, optimize dosing, and navigate complex regulatory requirements for safer, more effective medicines.
Insilico Medicine
Insilico Medicine provides an end-to-end generative AI platform designed to accelerate drug discovery and development by identifying novel targets and generating molecular structures for various diseases and aging processes.
Quick Comparison
| Feature | Certara | Insilico Medicine |
|---|---|---|
| Website | certara.com | insilico.com |
| Pricing Model | Custom | Custom |
| Starting Price | Custom Pricing | Custom Pricing |
| FREE Trial | ✘ No free trial | ✘ No free trial |
| Free Plan | ✘ No free plan | ✘ No free plan |
| Product Demo | ✓ Request demo here | ✓ Request demo here |
| Deployment | ||
| Integrations | ||
| Target Users | ||
| Target Industries | ||
| Customer Count | 0 | 0 |
| Founded Year | 2008 | 2014 |
| Headquarters | Princeton, USA | Hong Kong, China |
Overview
Certara
Certara offers a comprehensive suite of biosimulation and regulatory software designed to transform how you develop new medicines. By using predictive modeling and simulation, you can virtually test drug candidates to determine optimal dosing and predict clinical outcomes before entering human trials. This approach helps you reduce the risk of failure and significantly shortens the time it takes to bring life-saving therapies to patients.
You can manage every stage of the lifecycle, from early discovery and pharmacokinetic analysis to automated regulatory submissions. The platform is built for pharmaceutical companies, biotech startups, and academic researchers who need to handle complex data with precision. Whether you are performing non-compartmental analysis or building sophisticated mechanistic models, you get the tools needed to make data-driven decisions and meet global health authority standards.
Insilico Medicine
Insilico Medicine offers a comprehensive generative AI platform called Pharma.AI that transforms how you approach drug discovery. You can navigate the entire R&D lifecycle—from identifying disease targets to generating novel molecular structures and predicting clinical trial outcomes—within a single integrated environment. This approach helps you significantly reduce the time and cost typically associated with bringing new therapeutics to market.
The platform is designed for pharmaceutical companies, biotechnology startups, and academic researchers who need to streamline complex biological data analysis. By using their specialized engines like PandaOmics and Chemistry42, you can uncover hidden disease pathways and design lead-like molecules with specific properties. It solves the traditional bottleneck of manual data synthesis, allowing your team to focus on high-value experimental validation.
Overview
Certara Features
- Phoenix WinNonlin Perform pharmacokinetic and pharmacodynamic modeling with the industry-standard tool for non-compartmental analysis and automated reporting.
- Simcyp PBPK Simulator Predict drug-drug interactions and outcomes in virtual populations to optimize your clinical trial designs and dosing strategies.
- Pinnacle 21 Validate your clinical data against CDISC standards to ensure your regulatory submissions are high-quality and ready for agency review.
- D360 Data Integration Access and visualize scientific data from multiple sources in a single workspace to identify promising drug candidates quickly.
- Global Submit Manage and publish your electronic Common Technical Document submissions to meet global regulatory requirements without manual errors.
- Integral Data Repository Store and track your clinical and non-clinical data in a 21 CFR Part 11 compliant environment for full traceability.
Insilico Medicine Features
- PandaOmics Target ID. Identify and prioritize therapeutic targets by analyzing massive datasets of omics, clinical trials, and grant information in minutes.
- Chemistry42 Molecular Design. Generate novel, lead-like molecular structures from scratch using over 40 generative models optimized for your specific biological targets.
- InClinico Trial Prediction. Predict the success probability of Phase II clinical trials to help you make better investment and portfolio management decisions.
- Generative Tensorial Reinforcement. Apply advanced reinforcement learning to optimize molecular properties like solubility, metabolic stability, and synthetic accessibility simultaneously.
- Automated Data Integration. Connect your internal proprietary data with vast public databases to create a unified knowledge graph for your research projects.
- Multi-Omics Analysis. Analyze transcriptomics, proteomics, and epigenomics data side-by-side to gain a holistic view of disease mechanisms and patient stratification.
Pricing Comparison
Certara Pricing
Insilico Medicine Pricing
Pros & Cons
Certara
Pros
- Industry-standard tools recognized by global regulatory agencies
- Highly accurate biosimulation reduces the need for animal testing
- Comprehensive data validation ensures faster regulatory approval cycles
- Excellent technical support from PhD-level domain experts
Cons
- Significant learning curve for advanced modeling features
- High cost of entry for small biotech startups
- Interface can feel dated compared to modern SaaS tools
Insilico Medicine
Pros
- Significantly reduces time for hit-to-lead identification
- Highly integrated workflow across target and chemistry modules
- User-friendly interface for complex biological data visualization
- Strong track record with several AI-discovered drugs in clinical trials
Cons
- High entry cost typical for enterprise biotech software
- Requires significant domain expertise in biology or chemistry
- Limited public documentation on specific pricing structures